MET targeted therapy in non-small cell lung cancer patients with <i>MET</i> exon 14-skipping mutations.

Jørgensen, Jan Trøst; Urbanska, Edyta M; Mollerup, Jens

MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations.

Jørgensen, Jan Trøst; Urbanska, Edyta M; Mollerup, Jens.

Afiliación

Jørgensen JT; Medical Sciences, Dx-Rx Institute, Fredensborg, Denmark.
Urbanska EM; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Mollerup J; Pathology Division, Agilent Technologies Denmark ApS, Glostrup, Denmark.

Transl Lung Cancer Res ; 13(4): 940-946, 2024 Apr 29.

Article en En | MEDLINE | ID: mdl-38736494

Palabras clave

MET exon 14-skipping mutations (METex14); Non-small-cell lung cancer (NSCLC); capmatinib; companion diagnostics; tepotinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google